Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units

被引:16
作者
Abramovich, E. [1 ,2 ]
Barrett, O. [1 ,2 ,3 ]
Dreiher, J. [4 ]
Novack, V. [1 ,2 ,3 ]
Abu-Shakra, M. [1 ,2 ,5 ]
机构
[1] Soroka Med Ctr, Dept Med, Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Clin Res Ctr, Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Clalit Hlth Serv, Beer Sheva, Israel
[5] Ben Gurion Univ Negev, Rheumat Dis Unit, Beer Sheva, Israel
关键词
Systemic lupus erythematosus; sepsis; mortality; infections; EPIDEMIOLOGY; VALIDATION; SURVIVAL; DEATH;
D O I
10.1177/0961203318796288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Infections are common among patients with systemic lupus erythematosus (SLE), and are associated with increased morbidity and mortality. Objectives To determine whether SLE is an independent risk factor for short- and long-term mortality in patients admitted to an intensive care unit (ICU) with sepsis, and to identify the characteristics of SLE patients admitted to an ICU with sepsis. Methods A retrospective age- and sex-matched cohort study, based on data of the SEPSIS-ISR (Sepsis Israel) Registry, an ongoing study that collects data on all patients admitted with sepsis to the ICUs. The primary outcome was to determine whether SLE is an independent risk factor for 30-day and 3-year mortality. Secondary outcomes were 30-day and 3-year survival rates, and the identification of variables associated with mortality within the group of patients with SLE. Results In total, 29 SLE and 87 non-SLE patients (median age 55 years; 79.3% females) were included. The primary sites of infection as well as pathogen distributions were similar between the two groups. The most common infections among the SLE and non-SLE patients were pneumonia (48.3 vs. 31%, p=0.09), urinary tract infection (20.7 vs. 14.9%, p=0.56) and peritonitis (13.8 vs. 16.1%, p=0.77). Severe sepsis and septic shock were diagnosed in 79.3 versus 80.5% (p=0.89) and 55.2 versus 33.3% (p=0.04) of the SLE and non-SLE patients, respectively. The 30-day and 3-year survival rates did not differ between SLE and non-SLE patients, and were 69 versus 67.8% (p=0.79) and 41.4 versus 47.1% (p=0.69), respectively. In multivariate Cox regression analysis, age (hazard ratio (HR)=1.02; 95% confidence interval (CI) 1.00-1.05) and cardiovascular involvement during sepsis (HR=3.32; 95% CI 1.4-7.86) were significant independent risk factors for 30-day mortality. Multiorgan dysfunction during sepsis admission was associated with increased 3-year mortality (HR=1.37; 95% CI 1.07-1.75). Conclusions SLE is not an independent risk factor for 30-day or 3-year mortality following ICU admission with sepsis. Increased late mortality was associated with congestive heart failure within the SLE patients alone. None of the SLE-related variables were statistically different between the living and deceased SLE patients.
引用
收藏
页码:1936 / 1943
页数:8
相关论文
共 19 条
[1]  
Abu-Shakra M, 2008, J RHEUMATOL, V35, P1906
[2]   Mortality and Multiple Causes of Death in Systemic Lupus Erythematosus - Role of the Death Certificate [J].
Abu-Shakra, Mahmoud ;
Novack, Victor .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) :458-460
[3]  
Barrett O, 2014, ISR MED ASSOC J, V16, P634
[4]   Epidemiology and risk profile of heart failure [J].
Bui, Anh L. ;
Horwich, Tamara B. ;
Fonarow, Gregg C. .
NATURE REVIEWS CARDIOLOGY, 2011, 8 (01) :30-41
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]   Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up [J].
Chen, M. -J. ;
Tseng, H. -M. ;
Huang, Y. -L. ;
Hsu, W. -N. ;
Yeh, K. -W. ;
Wu, T. -L. ;
See, L. -C. ;
Huang, J. -L. .
RHEUMATOLOGY, 2008, 47 (09) :1352-1357
[7]   Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: A multicenter analysis [J].
Dreiher, Jacob ;
Almog, Yaniv ;
Sprung, Charles L. ;
Codish, Shlomi ;
Klein, Moti ;
Einav, Sharon ;
Bar-Lavie, Yaron ;
Singer, Pierre P. ;
Nimrod, Adi ;
Sachs, Jeffrey ;
Talmor, Daniel ;
Friger, Michael ;
Greenberg, Dan ;
Olsfanger, David ;
Hersch, Moshe ;
Novack, Victor .
CRITICAL CARE MEDICINE, 2012, 40 (03) :855-860
[8]   Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years [J].
Fei, Yunyun ;
Shi, Xiaochun ;
Gan, Fengying ;
Li, Xuemei ;
Zhang, Wen ;
Li, Mengtao ;
Hou, Yong ;
Zhang, Xuan ;
Zhao, Yan ;
Zeng, Xiaofeng ;
Zhang, Fengchun .
CLINICAL RHEUMATOLOGY, 2014, 33 (01) :57-63
[9]   The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus [J].
Gladman, D ;
Ginzler, E ;
Goldsmith, C ;
Fortin, P ;
Liang, M ;
Urowitz, M ;
Bacon, P ;
Bombardieri, S ;
Hanly, J ;
Hay, E ;
Isenberg, D ;
Jones, J ;
Kalunian, K ;
Maddison, P ;
Nived, O ;
Petri, M ;
Richter, M ;
SanchezGuerrero, J ;
Snaith, M ;
Sturfelt, G ;
Symmons, D ;
Zoma, A .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :363-369
[10]   The epidemiology of sepsis [J].
Hodgin, Katherine E. ;
Moss, Marc .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (19) :1833-1839